Comment on primary site tumours from the ECC 2013 Scientific Co-Chair
Comment on primary site tumours from the ECC 2013 Scientific Co-Chair
Identifying disease-causing mechanisms in cancers with unknown primary site i
ecancerNews Highlights from September 2013
Latest on the WINTHER trial
Challenges and opportunities for implementing personalized medicine in Brazil
Delivering stratified medicine using next generation sequencing
Development of information systems that identify genomic biomarkers
ECC 2013 Preview: Scientific programme highlights
Comment on progression free survival in lung cancer patients and the GALAXY-1 trial
Crizotinib and molecular testing in advanced non small cell lung cancer
Nintedanib in combination with standard second line therapy in lung cancer
One in five african american women with breast cancer carry inherited mutations